Arkolith/Insider Trading/TMDX/Form 4

Basile Edward M

DirectorTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Nov 7, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$564K
Net Open-Market Flow
-$564K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 5, 2024Option exercise(M)7K$28.12$190K7K
Nov 5, 2024Sell(S)1K$84.30$123K732
Nov 5, 2024Sell(S)5K$83.35$441K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 5, 2024Option exercise(M)7K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-123425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML